Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teneligliptin in Japanese type 2 diabetes mellitus
NCT00998881Phase 3Completed
- Sponsor
- Mitsubishi Tanabe Pharma
- Start
- Sep 2009
- Primary completion
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Teneligliptin 20 mg with Placebo (2 arms). Primary endpoint: Glycated Hemoglobin at 12 weeks. Started Sep 2009; status: completed.
02
Drugs
teneligliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00998881.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00998881.